Takeda Pharmaceutical (TAK) Assets Average (2022 - 2025)
Takeda Pharmaceutical (TAK) has 4 years of Assets Average data on record, last reported at $174.4 billion in Q1 2025.
- For Q1 2025, Assets Average fell 25.91% year-over-year to $174.4 billion; the TTM value through Mar 2025 reached $174.4 billion, down 25.91%, while the annual FY2022 figure was $119.6 billion, N/A changed from the prior year.
- Assets Average reached $174.4 billion in Q1 2025 per TAK's latest filing, down from $235.4 billion in the prior quarter.
- Across five years, Assets Average topped out at $304.0 billion in Q1 2022 and bottomed at $174.4 billion in Q1 2025.
- Average Assets Average over 4 years is $252.9 billion, with a median of $266.7 billion recorded in 2023.
- Peak YoY movement for Assets Average: fell 1.96% in 2023, then decreased 25.91% in 2025.
- A 4-year view of Assets Average shows it stood at $304.0 billion in 2022, then decreased by 1.96% to $298.0 billion in 2023, then dropped by 21.02% to $235.4 billion in 2024, then decreased by 25.91% to $174.4 billion in 2025.
- Per Business Quant database, its latest 3 readings for Assets Average were $174.4 billion in Q1 2025, $235.4 billion in Q1 2024, and $298.0 billion in Q1 2023.